Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Not Applicable
Terminated
- Conditions
- Opioid Use
- Registration Number
- NCT06217380
- Lead Sponsor
- Masimo Corporation
- Brief Summary
This Clinical Trial will evaluate the Feasibility and Acceptability of Oxygen Saturation Monitoring using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program 2-4 weeks Summarizing proportion of lost components to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie opioid-induced respiratory depression monitored by MSNA?
How does MSNA compare to pulse oximetry in detecting hypoxemia among opioid users in supportive housing?
Are there specific biomarkers that correlate with improved outcomes using MSNA in opioid use populations?
What adverse events are associated with continuous oxygen saturation monitoring in opioid use disorder patients?
How does MSNA integration with existing opioid management protocols affect clinical outcomes in housing programs?
Trial Locations
- Locations (1)
Research Site
🇨🇦Vanier, Canada
Research Site🇨🇦Vanier, Canada